[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"painless-abortion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:painless-abortion":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100603102","reinforcement-learned-automated-anesthesia-systems-during-painless-abortion-100603102",false,"NCT07132151","Reinforcement Learned Automated Anesthesia Systems During Painless Abortion","Automated Anesthesia Systems for Painless Abortion (AAS-PA): a Multi-center, Randomized Controlled Trial","AAS-PA","Inclusion Criteria:\n\n* Age between 18-45 years\n* ASA status Ⅰ to Ⅱ\n* Diagnosed with early intrauterine pregnancy\n* Body mass index (BMI) between 18 to 28 kg\u002Fm2\n\nExclusion Criteria:\n\n* History of cardiac, hepatic, renal, or metabolic disorders (e.g., diabetes, hypertension, sleep apnea)\n* Known allergy to opioids or ciprofloxacin components\n* Cachexia\n* History of substance or alcohol abuse\n* ASA class III or higher\n* Participation in any other drug clinical trial within the past 3 months\n* Long-term use of sedative or analgesic medications\n* History of neurological disorders and convulsions",true,"FEMALE","18 Years","45 Years",{"count":22,"type":23},167,"ESTIMATED","INTERVENTIONAL",[26],"NA","This study compares the automated anesthesia systems for painless abortion (AAS-PA) with traditional anesthesia in painless abortions. It assesses intraoperative indicators (hypoxemia, injection pain, hypotension, hemodynamics, respiratory depression) and postoperative outcomes (nausea, dizziness, recovery time, satisfaction). The AAS-PA group uses AI-adjusted intravenous ciprofol based on real-time vital signs and sedation depth; the traditional group relies on manual anesthesia. The goal is to verify if AAS-PA safely manages sedation, meets painless standards, reduces adverse events, and improves experience, aiding optimized automated protocols.",[29,30,31],"Painless Abortion","Artificial Intelligence (AI)","Ciprofol","NOT_YET_RECRUITING","2025-08-18",{"date":35,"type":36},"2025-08-20","ACTUAL",{"date":38,"type":23},"2025-09-08",{"date":40,"type":23},"2027-11-08",{"name":42,"class":43},"Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.","INDUSTRY",8]